Skip to Content
Contact Form Map & Directions Videos

Category: Defective Drugs

FDA Eyes Pradaxa Again

02/6/2014
Articles
BY

Despite all the company assurances that the anticoagulant Pradaxa is a superior alternative to warfarin, the Food and Drug Administration (FDA) plans to once again compare the two. Pradaxa was approved in 2010 but has since then brought a high complication rate to its users  – including dangerous and uncontrolled bleeding […]

Read More

FDA Fails in Many Drug and Device Reviews

01/29/2014
Defective Drugs
BY

A trio of studies published in the Journal of the American Medical Association (JAMA) finds that just because a drug or medical device makes it to market does not necessarily mean it’s been tested and is safe and effective beyond all doubt. According to three published reviews, the same standards […]

Read More

Novartis Denied U.S. Supreme Court Consideration

01/14/2014
Defective Drugs
BY

The U.S. Supreme Court has denied a request by drugmaker Novartis to revisit the issue of whether punitive damages can be awarded in product liability lawsuits. Claiming immunity under the Food and Drug Administration (FDA), Novartis claimed that the FDA preempts state tort law which does allow punitive damages when […]

Read More

The Selling of ADHD

01/13/2014
Articles
BY

It’s been twenty years since a concerted effort, and some would say push, has been on to have children diagnosed with attention deficit hyperactivity disorder (ADHD) and the numbers prove the push translated into big dollars for Big Pharma. The Centers for Disease Control and Prevention (CDC) reports the number […]

Read More

GSK Will Stop Buying Favor Among Doctors – Or So It Says

01/9/2014
Articles
BY

It is called an industry first. GlaxoSmithKline (GSK) has vowed to stop compensating medical doctors in order to have them promote the company’s drugs. The British drug maker announced this month it will also stop paying healthcare professionals who attend their medical conferences saving the company about $82 million a […]

Read More

Four New Plaintiffs in National Actos Litigation

01/8/2014
Defective Drugs
BY

The Mass Tort Unit of Searcy Denney Scarola Barnhart & Shipley has filed additional individual lawsuits against Takeda Pharmaceuticals USA, Eli Lilly, and other drug companies involved in the development and marketing of Actos (which is also known as pioglitazone). This latest filing includes four Florida plaintiffs, all of whom […]

Read More

Hear What Our Clients Have To Say

"Nick DeBellis obtained the maximum recovery of full insurance limits in the case we worked on. He is a true professional and recommend him to anyone in South Florida."
Posted By: Michael Geoffroy